thalomid

Generic: thalidomide

Labeler: celgene corporation
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name thalomid
Generic Name thalidomide
Labeler celgene corporation
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

thalidomide 50 mg/1

Manufacturer
Celgene Corporation

Identifiers & Regulatory

Product NDC 59572-205
Product ID 59572-205_58b287d1-24f5-4dfe-84ca-898a8a5b9302
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA020785
Listing Expiration 2026-12-31
Marketing Start 2003-06-20

Pharmacologic Class

Physiologic Effect
decreased immunologically active molecule activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 59572205
Hyphenated Format 59572-205

Supplemental Identifiers

RxCUI
200390 213360 360176 360177 404449 404450 700416 700418
UNII
4Z8R6ORS6L
NUI
N0000008663

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name thalomid (source: ndc)
Generic Name thalidomide (source: ndc)
Application Number NDA020785 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 50 mg/1
source: ndc
Packaging
  • 10 BLISTER PACK in 1 BOX (59572-205-94) / 28 CAPSULE in 1 BLISTER PACK (59572-205-14)
  • 10 BLISTER PACK in 1 BOX (59572-205-97) / 1 CAPSULE in 1 BLISTER PACK (59572-205-17)
source: ndc

Packages (2)

Ingredients (1)

thalidomide (50 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "58b287d1-24f5-4dfe-84ca-898a8a5b9302", "openfda": {"nui": ["N0000008663"], "unii": ["4Z8R6ORS6L"], "rxcui": ["200390", "213360", "360176", "360177", "404449", "404450", "700416", "700418"], "spl_set_id": ["2eda833b-1357-4ed4-a093-194524fcb061"], "pharm_class_pe": ["Decreased Immunologically Active Molecule Activity [PE]"], "manufacturer_name": ["Celgene Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 BLISTER PACK in 1 BOX (59572-205-94)  / 28 CAPSULE in 1 BLISTER PACK (59572-205-14)", "package_ndc": "59572-205-94", "marketing_start_date": "20030620"}, {"sample": false, "description": "10 BLISTER PACK in 1 BOX (59572-205-97)  / 1 CAPSULE in 1 BLISTER PACK (59572-205-17)", "package_ndc": "59572-205-97", "marketing_start_date": "20110126"}], "brand_name": "Thalomid", "product_id": "59572-205_58b287d1-24f5-4dfe-84ca-898a8a5b9302", "dosage_form": "CAPSULE", "pharm_class": ["Decreased Immunologically Active Molecule Activity [PE]"], "product_ndc": "59572-205", "generic_name": "Thalidomide", "labeler_name": "Celgene Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Thalomid", "active_ingredients": [{"name": "THALIDOMIDE", "strength": "50 mg/1"}], "application_number": "NDA020785", "marketing_category": "NDA", "marketing_start_date": "20030620", "listing_expiration_date": "20261231"}